アオキ ユウジ
Yuji.AOKI
青木 雄次
- 所属 松本大学大学院 健康科学研究科 健康科学専攻
- 松本大学 人間健康学部 健康栄養学科
- 職種 教授
| 言語種別 | 英語 |
| 発行・発表の年月 | 2016/10 |
| 形態種別 | 速報，短報，研究ノート等（学術雑誌） |
| 査読 | 査読あり |
| 標題 | Comparison of diuretic effects between empagliflozin, a sodium-glucose co-transporter 2 inhibitor with osmotic diuresis, and tolvaptan, a water diuretic, in two type 2 diabetic patients taking sodium diuretics. |
| 執筆形態 | 単著 |
| 掲載誌名 | Diabetes Research Open Journal |
| 掲載区分 | 国外 |
| 巻・号・頁 | 2(2),pp.45-49 |
| 総ページ数 | 5 |
| 担当範囲 | All |
| 著者・共著者 | Yuji Aoki |
| 概要 | Empagliflozin, one of sodium-glucose co-transporter 2 (SGLT2) inhibitors, has been demonstrated to have beneficial effects on cardiovascular morbidity and mortality in patients with type 2 diabetes at high risk for cardiovascular events. The mechanisms behind these benefits of empagliflozin are presumed to include osmotic diuresis, being rather close to water diuresis than sodium diuresis. Two cases are presented here, where distinct changes in urinary water and sodium excretion were seen immediately after replacing tolvaptan, a water diuretic, with empagliflozin. |